Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2126
| Subject | Predicate | Object | Context |
|---|---|---|---|
| dailymed-drugs:2126 | rdf:type | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2126 | rdf:type | dailymed-instance:drugs | lld:dailymed |
| dailymed-drugs:2126 | rdfs:label | Humatin (Capsule) | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:dosage | Intestinal amebiasis: Adults and Pediatric Patients: Usual dose������25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days. Management of hepatic coma: Adults: Usual dose������4 g daily in divided doses, given at regular intervals for five to six days. | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:descripti... | Humatin is a broad spectrum antibiotic produced by Streptomyces rimosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product supplied as capsules containing the equivalent of 250 mg paromomycin. The capsule contains D&C yellow No. 10; FD&C blue No. 1; FD&C red No. 3; FD&C yellow No. 6; gelatin, NF; and titanium dioxide, USP. | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:activeIng... | dailymed-ingredient:Paromom... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:contraind... | Paromomycin sulfate is contraindicated in individuals with a history of previous hypersensitivity reactions to it. It is also contraindicated in intestinal obstruction. | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:supply | Humatin Capsules, each containing paromomycin sulfate equivalent to 250 mg paromomycin, are supplied as follows NDC 61570-529-10: Bottles of 100 Store at controlled room temperature 15�����30��C (59�����86��F). Protect from moisture. Rx only. Prescribing Information as of November 2001. Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620 Manufactured by: Caraco Pharmaceutical Laboratories, Ltd., Detroit, MI 48202 | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:activeMoi... | dailymed-ingredient:Paromom... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:gelatin | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:titaniu... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:FD&C_ye... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:D&C_yel... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:FD&C_re... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:inactiveI... | dailymed-ingredient:FD&C_bl... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:precautio... | The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. Constant observation of the patient is essential. If new infections caused by nonsusceptible organisms appear during therapy, appropriate measures should be taken. The drug should be used with caution in individuals with ulcerative lesions of the bowel to avoid renal toxicity through inadvertent absorption. Pediatric Use: See Dosage and Administration section. | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:genericMe... | Paromomycin Sulfate | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:fullName | Humatin (Capsule) | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:adverseRe... | Nausea, abdominal cramps, and diarrhea have been reported in patients on doses over 3 g daily. | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:represent... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:routeOfAd... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:2126 | dailymed-instance:name | Humatin | lld:dailymed |
| http://www4.wiwiss.fu-berli... | dailymed-instance:producesD... | dailymed-drugs:2126 | lld:dailymed |